The role of Stromal Cell-Derived Factor 1 (SDF-1) and Transforming Growth-Factor-Beta 1 (TGF-?1) levels in Packed Red Cells (PRC) as the indicator of storage lesion at Sanglah Hospital-Blood Bank, Bali, Indonesia

Anak Agung Wiradewi Lestari; Ni Kadek Mulyantari; I Putu Yuda Prabawa

doi:10.15562/ijbs.v16i1.374

The role of Stromal Cell-Derived Factor 1 (SDF-1) and Transforming Growth-Factor-Beta 1 (TGF-?1) levels in Packed Red Cells (PRC) as the indicator of storage lesion at Sanglah Hospital-Blood Bank, Bali, Indonesia

Anak Agung Wiradewi Lestari ,

Ni Kadek Mulyantari ,

I Putu Yuda Prabawa ,

PDF |
DOI: https://doi.org/10.15562/ijbs.v16i1.374 |
Published: 2022-01-27

Abstract

Background: Packed Red Cells (PRC) is one of the blood component obtained from the whole blood through the removal of blood plasma. The storage of PRC aims to maintain the viability and function of erythrocytes by reducing cell metabolic activity. However, PRC's biochemistry changes could occur through storage lesion by releasing Stromal Cell-Derived Factor 1 (SDF-1) and Transforming Growth Factor-Beta 1 (TGF-?1) that affect the erythrocytes metabolism and viability prior to transfusion. This study aims to evaluate the increase of SDF-1 and TGF-?1 levels in PRC as the indicator of storage lesion at Sanglah Hospital-Blood Bank, Bali, Indonesia.

Methods: An observational cross-sectional study using randomized post-test only without control group design was conducted at Sanglah Hospital-Blood Bank, Bali. The consecutive random sampling technique was used in this study to the PRC, who met the inclusion criteria. Samples of the SDF-1 group (N=84) were divided into 3 such as Group 1 (1-7 days), Group 2 (8-14 days), and Group 3 (15-21 days). However, 53 PRC was divided into 2 groups as Group 1 (1-7 days) and Group 2 (8-14 days). The SDF-1 and TGF-?1 levels were evaluated for each group using Human SDF-1/CXCL12 and TGF-?1 Kit from Elabcience® by ELISA method. Data were analyzed using SPSS version 25 for Windows software.

Results: The median levels of SDF-1 in Group 1 group was 0.385 (0.050-1.020) ng/mL, followed by 0.455 (0.330-0.750) ng/ml in Group 2, and 0.490 (0.380-0.920) ng/ml in Group 3 (p<0.05). The mean of TGF-?1 levels was slightly higher in Group 1 (2,365.21±715.96 pg/ml) compared with Group 2 (2,210.39±994.68 pg/ml) (p=0.523). There was a significant difference in SDF-1 levels in Group 1-Group 2 (P=0.041) and Group 1-Group 3 (P=0.000) groups; however, no significant difference was found in Group 2-Group 3 (P=0.133) using the Mann-Whitney test. The Spearman's rho test found a moderate positive correlation between SDF-1 levels and storage time by day (r=0.546; P=0.000). In addition, based on the Pearson correlation test, there was a weak positive correlation between TGF-?1 levels and storage time by day (r=0.461; p=0.001).

Conclusion: The increase of SDF-1 and TGF-?1 levels in PRC by days of storage time could be used as the indicator for storage lesion at Sanglah General Hospital-Blood Bank, Bali, Indonesia.

References

1. Storch EK, Custer BS, Jacobs MR, Menitove JE, Mintz PD. Review of current transfusion therapy and blood banking practices. Blood Rev. 2019;38:100593.
2. Mulyantari NK, Prabawa IPY. Analysis of Soluble Cluster of Differentiation 40 Ligand (SD40L) levels between thrombocyte apheresis and thrombocyte whole blood products in Sanglah General Hospital blood bank. Bali Medical Journal. 2018;8(1):173-178.
3. Kor DJ, Van Buskirk CM, Gajic O. Red blood cell storage lesion. Bosn J Basic Med Sci. 2009;9 Suppl 1:21-27.
4. van de Watering LM, Brand A. Effects of storage of red cells. Transfus Med Hemother. 2008;35(5):359-367.
5. Kim-Shapiro DB, Lee J, Gladwin MT. Storage lesion: role of red blood cell breakdown. Transfusion. 2011;51(4):844-851.
6. Hod EA, Spitalnik SL. Harmful effects of transfusion of older stored red blood cells: iron and inflammation. Transfusion. 2011;51(4):881-885.
7. Sut C, Tariket S, Chou ML, Garraud O, Laradi S, Hamzeh-Cognasse H, et al. Duration of red blood cell storage and inflammatory marker generation. Blood Transfus. 2017;15(2):145-152.
8. De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R, et al. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1 beta explains functional diversity. Blood. 2004;103(7):2452-9.
9. Lee JS, Gladwin MT. The Risk of Red Cell Storage. Nat Med. 2010;16(4):381–382.
10. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol. 1998;16:137-161.
11. Zimrin AB, Hess JR. Current issues relating to the transfusion of stored red blood cells. Vox Sang. 2009;96(2):93-103.
12. Radwanski K, Garraud O, Cognasse F, Hamzeh-Cognasse H, Payrat JM, Min K. The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response. Transfusion. 2013;53(12):3128-3138.
13. Hess JR. Measures of stored red blood cell quality. Vox Sang. 2014;107(1):1-9.
14. Gazitt Y, Liu Q. Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34+ cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients. Stem Cells. 2001;19(1):37-45.
15. Christersson C, Johnell M, Siegbahn A. Evaluation of microparticles in whole blood by multicolour flow cytometry assay. Scand J Clin Lab Invest. 2013;73(3):229-239.
16. Zimring JC. Established and theoretical factors to consider in assessing the red cell storage lesion. Blood. 2015;125(14):2185-2190.
17. Pallotta V, Rinalducci S, Zolla L. Red blood cell storage affects the stability of cytosolic native protein complexes. Transfusion. 2015;55(8):1927-1936. doi:10.1111/trf.13079
18. D'Alessandro A, D'Amici GM, Vaglio S, Zolla L. Time-course investigation of SAGM-stored leukocyte-filtered red bood cell concentrates: from metabolism to proteomics. Haematologica. 2012;97(1):107-115.
19. Kriebardis AG, Antonelou MH, Stamoulis KE, Economou-Petersen E, Margaritis LH, Papassideri IS. Progressive oxidation of cytoskeletal proteins and accumulation of denatured hemoglobin in stored red cells. J Cell Mol Med. 2007;11(1):148-155.
20. Almizraq R, Tchir JD, Holovati JL, Acker JP. Storage of red blood cells affects membrane composition, microvesiculation, and in vitro quality. Transfusion. 2013;53(10):2258-2267.
21. Bicalho B, Holovati JL, Acker JP. Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles. Biochim Biophys Acta. 2013;1828(2):317-326.
22. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996;184(3):1101-1109.
23. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, et ak. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. 2003;362(9385):697-703.
24. Lataillade JJ, Clay D, Bourin P, Hérodin F, Dupuy C, Jasmin C, et al. Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood. 2002;99(4):1117-29.
25. Lin TJ, Issekutz TB, Marshall JS. SDF-1 induces IL-8 production and transendothelial migration of human cord blood-derived mast cells. Int Arch Allergy Immunol. 2001;124(1-3):142-145.
26. Radwanski K, Garraud O, Cognasse F, Hamzeh-Cognasse H, Payrat JM, Min K. The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response. Transfusion. 2013;53(12):3128-3138.
27. Cognasse F, Garraud O, Hamzeh-Cognasse H, Damien P, Nguyen KA, Pozzetto B, et al. Investigative in vitro study about red blood cell concentrate processing and storage. Am J Respir Crit Care Med. 2013;187(2):216-7.
28. Bardyn M, Maye S, Lesch A, Delobel J, Tissot JD, Cortés-Salazar F, et al. The antioxidant capacity of erythrocyte concentrates is increased during the first week of storage and correlated with the uric acid level. Vox Sang. 2017;112(7):638-647.
29. Rodgers GP, Lichtman HC, Sheff MF. Red blood cell glucose-6-phosphate dehydrogenase activity in aged humans. J Am Geriatr Soc. 1983;31(1):8-11.
30. Chin D, Boyle GM, Parsons PG, Coman WB. What is transforming growth factor-beta (TGF-beta)?. Br J Plast Surg. 2004;57(3):215-221.
31. Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S. TGF-? - an excellent servant but a bad master. J Transl Med. 2012;10:183.
32. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet. 2001;29(2):117-129.
33. Xiao YQ, Freire-de-Lima CG, Schiemann WP, Bratton DL, Vandivier RW, Henson PM. Transcriptional and translational regulation of TGF-beta production in response to apoptotic cells. J Immunol. 2008;181(5):3575-3585.
34. Poniatowski ?A, Wojdasiewicz P, Gasik R, Szukiewicz D. Transforming growth factor Beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications. Mediators Inflamm. 2015;2015:137823.

The role of Stromal Cell-Derived Factor 1 (SDF-1) and Transforming Growth-Factor-Beta 1 (TGF-?1) levels in Packed Red Cells (PRC) as the indicator of storage lesion at Sanglah Hospital-Blood Bank, Bali, Indonesia

Abstract

References

How to Cite

Search Panel